CELL DEATH DIFFER 润色咨询

CELL DEATH AND DIFFERENTIATION

出版年份:1994 年文章数:2573 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2023-06-01 尊严

    偏重的研究方向:分子生物学
    经验分享:能比的上NC和Sci Adv不?

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2020-05-16 599

    同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?yushnahe 2020-02-14 00:00:00 发表:
    我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor

    yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2021-04-16 里开朗琪罗

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2021-10-04 darktempler

    最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2020-08-31 wisper speed

    让我转小cdd

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2020-02-14 yushnahe

    我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor东瓜 2020-02-13 发表::
    12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢
    东瓜 2020-02-13 00:00:00 发表:
    12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢

    东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2024-01-20 ms7000001151045825 来自黑龙江省

    请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection.

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2023-10-13 雨念 来自浙江省

    请问大家需要推荐的Receiving Editor从哪里找呀

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2023-04-02 ms4000000052815042 来自北京

    Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2140353, encodeId=b699214035354, content=偏重的研究方向:分子生物学<br>经验分享:能比的上NC和Sci Adv不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Thu Jun 01 17:31:11 CST 2023, time=2023-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590997, encodeId=e36959099ee0, content=同样投稿的时候没有推荐receiving editor,请问前辈后来多久后显示editor assigned的呢?<span class="quote">yushnahe 2020-02-14 00:00:00 发表:<br>我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor</span>, beContent=yushnahe 2020-02-14 00:00:00 发表: 我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0db65324031, createdName=599, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957730, encodeId=d8f395e73007, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:最近刚接收一篇,写下经验吧,希望对后来人投稿有帮助。投稿时间:2020年10月22日,收到返修意见:2020年12月10日,修回重投:2021年3月24日,接收:2021年4月16日。其中状态一般就是Under Consideration,返修时也可能是Waiting for Revision,最终接收为Accepted,一般就这几种状态。该杂志在细胞死亡领域还算比较好的杂志,杂志投稿时一定要注意偏好,范围是细胞死亡领域,注重分子机制的详细研究。对创新性也有一定的要求,但不算苛刻,发现新的基因,新的机制都可以,但对机制的要求算比较高的。两个审稿人,其中一个审稿人四五条意见,另一个多点,提了八九条。综合下来,两个人提的意见不少重复的,按照他们的意见安排好实验计划,争分夺秒补实验,给的修改时间是4个月内完成。从投稿到接收总共大约半年时间。做了六年的成果,发个文章挺不容易的。大家有什么疑问可以留言。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1cb35481290, createdName=里开朗琪罗, createdTime=Fri Apr 16 22:28:58 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057449, encodeId=85d9105e449d6, content=最近审稿可一篇大CDD的文章,我自己的文章发在小CDD上,做的组蛋白变体,这篇文章跟我做的一个变体,估计编辑就让我来审稿了。文章是新加坡的一个研究团队做的,做得很细致,我对文章的整体逻辑踢了几个问题,给了大修,最后杂志社参考了我的意见给了大修。估计修回来应该还会发给我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Oct 04 11:45:50 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881471, encodeId=937a8814e106, content=让我转小cdd, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=wisper speed, createdTime=Mon Aug 31 19:16:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584718, encodeId=2acf584e18f7, content=我1月28号投的,到现在17天了,投稿的时间没有推荐editor。现在的状态还是under consideration,但是receiving editor显示not assigned。你们投稿的时候这个显示什么状态?不知道文章是送审了呢,还是还没有指派editor<span class="quote">东瓜 2020-02-13 发表::<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span><span class="quote">东瓜 2020-02-13 00:00:00 发表:<br>12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢</span>, beContent=东瓜 2020-02-13 发表:: 12月24号投稿,28号变成submission,到目前47天了,还是under consideration,什么情况?好慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be2d1688291, createdName=yushnahe, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2162625, encodeId=6d5e216262569, content=请问大家需要推荐的Receiving Editor从哪里找呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Fri Oct 13 18:05:02 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2123272, encodeId=0feb21232e215, content=Decision made状态已经2周了,仍未收到审稿意见,需要写信催一下编辑吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6508518441, createdName=ms4000000052815042, createdTime=Sun Apr 02 14:09:14 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217633, encodeId=a9f8121e63393, content=偏重的研究方向:细胞死亡<br>经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86715207772, createdName=14752973m42暂无昵称, createdTime=Sat May 07 14:50:19 CST 2022, time=2022-05-07, status=1, ipAttribution=)]
    2022-05-07 14752973m42暂无昵称

    偏重的研究方向:细胞死亡
    经验分享:没推荐编辑 21天assigned 33天出现zip for reviewer 状态一直是under consideration 等的太心焦了

    4

    展开4条回复
共500条页码: 3/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分